| Product Name | MF | CAS | Details |
|---|
| PUN-96956 | C21H33ClN2 | 1144496-95-6 | Details |
| ML-077 | C17H16N4OS2 | 1135304-61-8 | Details |
| VU0621623 | C20H21F2N5O3S | 1115899-15-4 | Details |
| CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
| ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
| 673-A | C15H13NO | 109437-62-9 | Details |
| CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
| MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
| N 0840 | C11H15N5 | 109292-91-3 | Details |
| KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
| ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
| ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
| E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
| COR167 | C28H38N2O2 | 1048038-90-9 | Details |
| Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
| Eleven-Nineteen-Leukemia Protein IN-2 | C22H23N5O2 | 2894121-78-7 | Details |
| Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
| 6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
| Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
| Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
| Carbonic anhydrase inhibitor 12 | C27H22BrN5O5S2 | 2883451-38-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-3 | C28H27N5O2 | 2894121-83-4 | Details |
| Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
| D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
| 5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
| ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-1 | C27H33N7O2 | 2894121-68-5 | Details |
| Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
| Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
| Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
| BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
| BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
| Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
| (R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
| Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
| PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
| P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
| Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
| 3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
| Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
| Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
| Tubulin polymerization-IN-40 | C24H22FNO5 | 2921670-94-0 | Details |
| Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
| P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
| 3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
| Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
| DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
| Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
| Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
| Antiproliferative agent-17 | C26H28N2OS | 2882206-08-6 | Details |
| ATM-3507 trihydrochloride | C37H47ClFN5O2 | 2438679-30-0 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| Enpp/Carbonic?anhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| Topoisomerase IV inhibitor 1 | C34H32FN7O6S | 2883403-42-5 | Details |
| MRS2768 tetrasodium salt | 2567869-47-8 | Details |
| Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
| RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
| β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
| DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
| (D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
| Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
| SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
| Metallo-β-lactamase-IN-9 | C13H12N6O3S | 1802363-75-2 | Details |
| (-)-15-Deoxyspergualin | 89149-10-0 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
| KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
| Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
| Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
| KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
| Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
| Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
| KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
| Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
| S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
| Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
| KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
| LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
| KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
| PI3K/mTOR Inhibitor-12 | C27H27F2N9O4S | 2891692-83-2 | Details |
| α-Synuclein inhibitor 8 | C24H20N2O6 | 2883627-64-1 | Details |
| Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
| KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
| SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
| KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
| Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
| Mtb-cyt-bd oxidase-IN-6 | C20H27NO | 1246461-10-8 | Details |
| SARS-CoV-2 3CLpro-IN-5 | C22H26ClF2N5O4 | 2913186-57-7 | Details |
| Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
| Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
| Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
| KRAS G12C inhibitor 32 | C29H30Cl3FN6O3 | 2756739-00-9 | Details |
| LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| (+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | ||||